Dominic Piscitelli, Chief Financial Officer at Oric Pharmaceuticals, Inc. (ORIC), sold 2,900 shares at $10.00 ($29K) on 2025-06-09, disclosed to the SEC on 2025-06-09.
Scheduled sale ($29k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 2,600 | $26K | 89.7% |
| 2 | $10.00 | 300 | $3K | 10.3% |
| Total | $10.01 avg | 2,900 | $29K | 100% |
| Filing → |
| ORIC | SELL | 2026-02-26 | $703K | — | Filing → |
| ORIC | SELL | 2025-12-17 | $194K | — | Filing → |
| ORIC | SELL | 2025-10-08 | $160K | — | Filing → |